RA
LLY icon

Ransom Advisory’s Eli Lilly LLY Stock Holding History

Ransom Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.46M Sell
2,291
-160
-7% -$153K 0.97% 26
2025
Q3 		$1.87M Buy
2,451
+1,300
+113% +$967K 0.84% 29
2025
Q2 		$897K Sell
1,151
-45
-4% -$35K 0.42% 51
2025
Q1 		$988K Hold
1,196
– – 0.49% 46
2024
Q4 		$923K Buy
1,196
+465
+64% +$385K 0.42% 50
2024
Q3 		$648K Buy
731
+34
+5% +$30.6K 0.3% 64
2024
Q2 		$631K Sell
697
-44
-6% -$35.2K 0.32% 65
2024
Q1 		$576K Buy
+741
New +$527K 0.31% 72

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ransom Advisory's LLY Position: Q4 2025 in Review

Ransom Advisory reduced its Eli Lilly (LLY) stake by 6.5% in Q4 2025, selling an estimated $153K and leaving 2,291 shares worth $2.46M. The position accounts for 0.97% of the portfolio, ranked #26.

Ransom Advisory first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Ransom Advisory held 2,291 shares of Eli Lilly worth $2.46M as of Q4 2025.
  • Ransom Advisory sold 160 Eli Lilly shares in Q4 2025, an estimated $153K.
  • Eli Lilly made up 0.97% of Ransom Advisory's portfolio in Q4 2025, its #26 holding.
  • Ransom Advisory first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.